17-44913733-C-T
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_002055.5(GFAP):c.613G>A(p.Glu205Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,459,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002055.5 missense
Scores
Clinical Significance
Conservation
Publications
- Alexander diseaseInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- Alexander disease type IIInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GFAP | NM_002055.5 | c.613G>A | p.Glu205Lys | missense_variant | Exon 3 of 9 | ENST00000588735.3 | NP_002046.1 | |
| GFAP | NM_001363846.2 | c.613G>A | p.Glu205Lys | missense_variant | Exon 3 of 10 | NP_001350775.1 | ||
| GFAP | NM_001242376.3 | c.613G>A | p.Glu205Lys | missense_variant | Exon 3 of 7 | NP_001229305.1 | ||
| GFAP | NM_001131019.3 | c.613G>A | p.Glu205Lys | missense_variant | Exon 3 of 8 | NP_001124491.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1459882Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726402 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Alexander disease Pathogenic:1Other:1
Variant summary: GFAP c.613G>A (p.Glu205Lys) results in a conservative amino acid change located in the Intermediate filament, rod domain (IPR039008) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251486 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.613G>A has been reported in the literature in at-least two individuals in a series affected with features of adult onset Alexander Disease (example, Pareyson_2008). However, the authors report that one of these two individuals was asymptomatic, normal neurological examination and no symptoms of Alexander Disease. These data do not allow any conclusion about variant significance. At our laboratory, this variant was observed in an adult individual and the mother, both of whom had clinical and/or MRI findings supporting a diagnosis of Alexander Disease as communicated. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
not provided Uncertain:1Other:1
- -
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 205 of the GFAP protein (p.Glu205Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Alexander disease (PMID: 18684770). This missense change has been observed in at least one individual who was not affected with GFAP-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 66488). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GFAP protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at